Statements (31)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Dragon
gptkb:Corticosteroid cardiac glycoside |
gptkbp:ATCCode |
C01AA13
|
gptkbp:CASNumber |
630-60-4
|
gptkbp:category |
natural product
metabolite |
gptkbp:chemicalFormula |
C29H44O12
|
gptkbp:effect |
increases cardiac contractility
can cause arrhythmia |
gptkbp:foundIn |
gptkb:Acokanthera_schimperi
gptkb:Strophanthus_gratus |
https://www.w3.org/2000/01/rdf-schema#label |
ouabain
|
gptkbp:IUPACName |
(3β,5β,11α,14β)-3-[(O-2,6-Dideoxy-β-L-arabino-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-L-arabino-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide
|
gptkbp:mechanismOfAction |
inhibits Na+/K+-ATPase
|
gptkbp:meltingPoint |
238–240 °C
|
gptkbp:molecularWeight |
584.65 g/mol
|
gptkbp:origin |
plant-derived
|
gptkbp:PubChem_CID |
439501
472805 |
gptkbp:routeOfAdministration |
intravenous
|
gptkbp:solubility |
soluble in water
|
gptkbp:studiedBy |
cardiac physiology
ion transport studies |
gptkbp:toxicity |
highly toxic
|
gptkbp:UNII |
6GOW5M8H1W
|
gptkbp:usedFor |
arrow poison
cardiac stimulant |
gptkbp:bfsParent |
gptkb:convallatoxin
gptkb:Cardenolides |
gptkbp:bfsLayer |
6
|